Sarah Hedtrich

Hedtrich obtained her PhD in Pharmaceutical Sciences in 2009. In 2015, she was appointed as an Assistant Professor at the Freie University of Berlin, Germany, and relocated her lab to the U of British Columbia, Canada, in 2019. Currently, she holds one of the prestigious Johanna-Quandt-Professorships at the BIH@Charité in Berlin and maintains an Affiliate Professorship with UBC. Her research centers around inflammatory and genetic diseases of human epithelia and bioengineering of complex, human disease models which are leveraged to develop personalized next-generation therapies.